Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CTAS | NEE |
|---|---|---|
| Price | $197.88 | $76.24 |
| Change today | ▲ 3.08% | ▼ 1.01% |
| Market cap | $79.05B | $159.03B |
| Return, 3 months | +16.1% | -12.3% |
| Return, year to date | +6.0% | -3.0% |
| Return, 1 year | -0.1% | +6.2% |
| P/E (TTM) | 39.0 | 17.1 |
| P/B | 15.2 | 2.8 |
| P/E percentile vs own 5y | 44th | 15th |
| Dividend yield | 0.95% | 3.12% |
| Revenue growth (YoY, latest qtr) | +8.9% | +12.4% |
| Net profit growth (YoY) | +14.0% | +60.0% |
| Gross margin | 50.7% | 61.0% |
| Operating margin | 23.3% | 28.3% |
| Net margin | 17.7% | 32.4% |
| Return on equity | 40.6% | 17.2% |
| Analyst target vs. price | +11.7% | +33.4% |
| Analyst buy share | 75% | 64% |
| RSI (14) | 42 | 25 |
| 30-day volatility | 14.8% | 12.2% |
| Max drawdown, 1 year | -20.0% | -19.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.